Schedule 13G ownership disclosure
Corbus Pharmaceuticals Holdings, Inc.
Security class unavailable · CUSIP: 21833P103
Event date: 2021-05-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,673,458
- Percent of class
- 5.3400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-21-025576
- Form type
- SC 13G
- Filer
- Corbus Pharmaceuticals Holdings, Inc.
- CIK
- CIK 1595097
- Filed
- May 11, 2021
- Reporting period
- May 10, 2021
- Description
- Schedule 13G beneficial ownership